Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin.

MLA

Emmerich, Petra, et al. “Limited Specificity of Commercially Available SARS-CoV-2 IgG ELISAs in Serum Samples of African Origin.” Tropical Medicine & International Health, vol. 26, no. 6, June 2021, pp. 621–31. EBSCOhost, https://doi.org/10.1111/tmi.13569.

APA

Emmerich, P., Murawski, C., Ehmen, C., Possel, R., Pekarek, N., Oestereich, L., Duraffour, S., Pahlmann, M., Struck, N., Eibach, D., Krumkamp, R., Amuasi, J., Maiga, A. O., Rakotozandrindrainy, R., Asogun, D., Ighodalo, Y., Kann, S., May, J., Tannich, E., & Deschermeier, C. (2021). Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin. Tropical Medicine & International Health, 26(6), 621–631. https://doi.org/10.1111/tmi.13569

Chicago

Emmerich, Petra, Carolin Murawski, Christa Ehmen, Ronald Possel, Neele Pekarek, Lisa Oestereich, Sophie Duraffour, et al. 2021. “Limited Specificity of Commercially Available SARS-CoV-2 IgG ELISAs in Serum Samples of African Origin.” Tropical Medicine & International Health 26 (6): 621–31. doi:10.1111/tmi.13569.